Rafferty Asset Management, LLC Celldex Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 90,990 shares of CLDX stock, worth $2.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,990

Previous 119,494 23.85%

Holding current value

$2.29 Million

Previous $4.42 Million 30.12%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $913,838 - $1.27 Million	-28,504 Reduced 23.85%	90,990 $3.09 Million
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $2.36 Million - $3.06 Million	-71,921 Reduced 37.57%	119,494 $4.42 Million
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $1.53 Million - $2.25 Million	43,406 Added 29.33%	191,415 $8.03 Million
Q4 2023 Feb 13, 2024	SELL	$22.61 - $40.65 $379,418 - $682,147	-16,781 Reduced 10.18%	148,009 $5.87 Million
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $1.04 Million - $1.53 Million	-40,718 Reduced 19.81%	164,790 $4.54 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $1.81 Million - $2.29 Million	59,772 Added 41.01%	205,508 $6.97 Million
Q1 2023 May 11, 2023	BUY	$34.78 - $47.43 $83,645 - $114,069	2,405 Added 1.68%	145,736 $5.24 Million
Q4 2022 Feb 13, 2023	SELL	$27.78 - $45.38 $1.79 Million - $2.92 Million	-64,362 Reduced 30.99%	143,331 $6.39 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $1.9 Million - $3.15 Million	83,887 Added 67.76%	207,693 $5.84 Million
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $665,143 - $1.21 Million	-32,446 Reduced 20.77%	123,806 $3.34 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $335,466 - $477,226	12,137 Added 8.42%	156,252 $5.32 Million
Q4 2021 Feb 10, 2022	BUY	$35.68 - $56.27 $3.1 Million - $4.89 Million	86,971 Added 152.2%	144,115 $5.57 Million
Q3 2021 Nov 10, 2021	SELL	$28.95 - $55.99 $618,285 - $1.2 Million	-21,357 Reduced 27.21%	57,144 $3.09 Million
Q2 2021 Aug 10, 2021	SELL	$20.71 - $35.37 $881,376 - $1.51 Million	-42,558 Reduced 35.15%	78,501 $2.63 Million
Q1 2021 May 10, 2021	BUY	$16.19 - $29.91 $1.54 Million - $2.85 Million	95,268 Added 369.38%	121,059 $2.49 Million
Q4 2020 Feb 10, 2021	BUY	$14.99 - $22.75 $386,607 - $586,745	25,791 New	25,791 $452,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.18B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Celldex Therapeutics, Inc. Transaction History